Excellent assay results. I averaged the ten samples and
Excellent assay results. I averaged the ten samples and get average of 6.17 grams per ton.
Those are excellent grades for any mine in the area. I used only the original value for Sample M-1 where the assay was repeated. Very minor diff if the lower, repeated test value had been used.
Always good to read the releases several times to tease some other info out. I infer the mine is operating from the wording. Employees are now being granted a stock incentive in addition to hourly pay. The fact they are willing to accept stock indicates they have faith in the mine and in Paul Thompson - at least i read it that way.
Doesn't state specifically that the conversion selling has concluded for the two March loans but it's implied and we'll know that later today by the trading action.
i like everything I see in this PR - still no production guidance but if those grades are on the pad and we recover 80 to 90% there will be gold, the mine will operate profitably with excess for development. This is a bootstrap operation so more equipment, larger crew, upgrades to everything will flow from cash generated by the mine.
Proof will come when we do get some revenue numbers. The next Quarterly (Jan, Feb, Mar) is combined with the Annual and out in mid July The 2nd quarter (Apr, May, Jun) should be the much better report from higher grade ore loading now as shown in this Assay Report. Hope we know sooner but that filing will be out in August I believe. I think company will release some favorable news well before that.
Thanks to GGB for the first hand accounts from his visits to the the mine site and conversations with people who know the facts. . Thanks to all who've stayed the course and supported this endeavor over the long haul and the short haul. We begin the day at 0.0023. I feel today is a turnaround day for Mexus and its share price.
Paul Thompson's 79th birthday in Thursday May 1st. The assay report gives him and us something to smile about. Happy Birthday to the CEO.
rjw/mkc
Mexus Gold US (MXSG) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Million-Dollar Waves in Real Estate Tell you what, there’s something electrifying about a $500 million milestone in the real estate game, and when it's all about short term rentals, you know folks are really onto something. The Short Term Shop isn't just flipping houses in Destin, 30A, and Panama City Beach—they're setting benchmarks. It takes more than a fancy suit...
Continue Reading
Revolutionizing Maternity Support at Saddleback Saddleback Medical Center in Laguna Hills, California, is stirring the waters with its groundbreaking expansion in maternity services. For the first time, an Orange County hospital—The Women’s Hospital at MemorialCare Saddleback Medical Center—is offering complimentary, around-the-clock in-house doulas. Not a luxury,...
Continue Reading
Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...
Continue Reading
Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...
Continue Reading
Florida's Ambitious Economic Goals When someone floats the idea of a state's economy cracking the top 10 globally by the year 2030, you've got to wonder if it's all sunshine and rainbows, or if there's some serious groundwork being laid. The Florida Chamber Foundation seems to think it's achievable. As the end of October rolls around, they're throwing the 2026 Future of...
Continue Reading
CourseArc's Landmark Deal with Public Colleges Well, slap me silly and call me a believer—looks like CourseArc just locked down a heck of a gig with a public college system that's head-over-heels squirming to meet shiny new accessibility demands. Nearly 200,000 learners are waiting at their gates, and this agreement is the lifeline for colleges to not only stay afloat...
Continue Reading
Well, isn’t this just a spicy tidbit from the real estate frontier? Oberndorf Real Estate Management and The Bascom Group are strutting into San Jose with a hefty $53.1 million deal that snags them the Museum Park Apartments. These guys aren't just dipping their toes; they’re cannonballing into the market with style. Now, exactly what does it mean for you and me?...
Continue Reading
MSA Gears Up for Q3 Earnings Call—Why It Matters At the crack of dawn on November 3, 2026, MSA Safety Incorporated (NYSE: MSA) is set to unravel the latest updates on their financial frontline. For those keeping a sharp eye on the safety gear behemoth, this isn’t just another earnings call—it's the kind of event that can make or break confidence in their stock....
Continue Reading
Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...
Continue Reading
Hydrogen Takes Center Stage in Urban Planning Well, I didn't see this one coming—a city that's planning the power before the buildings. We're talking about ELISIUM, the so-called cognitive city destined to rise in Hendry County, Florida. And leading the charge in all this energy planning? None other than VIVIFY Technology, set to bring in its hydrogen expertise right...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Developments from Mozart Therapeutics Recent findings from Mozart Therapeutics shine a spotlight on MTX-201, a groundbreaking bispecific antibody designed to treat inflammatory bowel disease (IBD). This innovative therapy selectively binds to CD8 regulatory T cells (Treg), with the potential to effectively eliminate pathogenic CD4 T cells and lessen inflammation,...
Continue Reading
Arixa Capital Achieves New Heights in Loan Originations Arixa Capital, a prominent private real estate lender, has officially crossed the impressive milestone of over $7 billion in total loan originations since its establishment. This remarkable achievement underscores the firm's commitment to providing flexible and reliable financing solutions to real estate...
Continue Reading
Synaffix and Illumina Join Forces for Breakthrough Technologies Synaffix B.V., a prominent biotechnology company renowned for its innovative clinical-stage bioconjugation platform technology, has announced a licensing agreement with Illumina, Inc., a leader in DNA sequencing technologies. This agreement allows Illumina access to Synaffix's patented metal-free click...
Continue Reading
Bristol Myers Squibb Gaining Traction in Colorectal Cancer Treatment Bristol Myers Squibb (NYSE: BMY) has recently secured a significant win by obtaining approval from the European Commission (EC) for its leading immunotherapy combinations. This approval is specifically for the use of Opdivo (nivolumab) combined with Yervoy (ipilimumab) as a first-line treatment option...
Continue Reading
Hillary F. Blackburn's Significant New Role The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have made an important announcement. They have appointed Hillary F. Blackburn, PharmD, MBA, as the first pharmacist voting member of the Advisory Committee on Immunization Practices (ACIP). This historic appointment...
Continue Reading